Microbot Medical Inc.
MBOT
$2.41
$0.114.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.85% | -16.64% | -21.77% | -13.79% | -6.55% |
| Total Depreciation and Amortization | -48.35% | -37.00% | -21.65% | -28.44% | -14.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.59% | -76.65% | -73.24% | -67.25% | -60.89% |
| Change in Net Operating Assets | -185.64% | 187.90% | 276.35% | 204.21% | 187.44% |
| Cash from Operations | -47.80% | -22.57% | -26.03% | -19.75% | -3.45% |
| Capital Expenditure | -140.00% | -223.08% | 29.27% | 48.94% | 24.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,730.22% | -2,399.73% | -7,561.89% | -923.99% | -22.13% |
| Cash from Investing | -4,809.43% | -2,412.64% | -8,637.98% | -903.14% | -22.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 986.69% | 1,596.04% | 705.70% | 265.79% | 18.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 986.69% | 1,596.04% | 735.80% | 272.36% | 21.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.39% | 829.63% | 149.82% | 307.79% | 32,400.00% |